Latest Schedule 13G passive stakes

Global X Management Company LLC has reported a beneficial ownership of 8.9% in Wabash National Corp, totaling over 3.6 million shares.

Global X Management Company LLC has reported a 5.64% passive ownership stake in Nano Nuclear Energy Inc., totaling nearly 3 million shares.

Global X Management Company LLC has reported a passive ownership stake of 5.5% in Hess Midstream LP, totaling over 7 million Class A shares.

Ning Ding and DNR Technology Co., Ltd. report a 59.62% beneficial ownership stake in ZJK Industrial Co., Ltd. following a share capital reorganization.

Global X Management Company LLC has reported a significant passive ownership stake of 6.96% in Community Healthcare Trust Inc.

Global X Management Company LLC has reported a beneficial ownership of 6.15% in Columbus McKinnon Corp, representing over 1.7 million shares held for investment purposes.

Jacob Suen has disclosed a beneficial ownership of 883,453 shares in Airgain, Inc., representing a 6.6% stake in the company.

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 6.43% beneficial ownership stake in OneIM Acquisition Corp.

Saba Capital Management, L.P. and Boaz R. Weinstein have filed a Schedule 13G reporting a 5.72% beneficial ownership stake in TaskUs, Inc.

Saba Capital Management has filed an amendment reporting a 14.35% beneficial ownership stake in the PIMCO Dynamic Income Strategy Fund.

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 13.94% beneficial ownership stake in M3-Brigade Acquisition V Corp.

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 6.95% beneficial ownership stake in Sharps Technology, Inc. common stock and warrants.

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 6.6% beneficial ownership stake in WEN Acquisition Corp.

Saba Capital Management has reported a 12.02% beneficial ownership stake in Vertical Aerospace Ltd. through a Schedule 13G filing.

Saba Capital Management and Boaz R. Weinstein have reported a 7.58% beneficial ownership stake in Republic Digital Acquisition Company.

Arena Investors LP and its affiliates have filed an amendment to their Schedule 13G, reporting a 0% beneficial ownership stake in U Power Ltd.

SoftBank Group Corp. and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Ethos Technologies Inc.

SoftBank Vision Fund (AIV M2) L.P. and SB Investment Advisers (UK) Limited report an 8.9% beneficial ownership stake in Energy Vault Holdings, Inc.

SoftBank Vision Fund entities have reported a 6.5% beneficial ownership stake in Vir Biotechnology, Inc. as of March 31, 2026.

Freebird Partners LP and affiliates have filed an amended Schedule 13G reporting a 9.9% beneficial ownership stake in Ernexa Therapeutics Inc.

John and Katherine Halpern have filed an amended Schedule 13G reporting a 5.6% beneficial ownership stake in Ernexa Therapeutics Inc.

ADAR1 Capital Management and Daniel Schneeberger have filed a Schedule 13G reporting a 9.9% beneficial ownership stake in Equillium, Inc.

A group of major shareholders, including members of the Bombardier family, filed an amended Schedule 13G to reflect the liquidation of Beaudier Holdings LP into Beaudier Inc.

Equitable Holdings, Inc. and its subsidiary have filed a Schedule 13G reporting beneficial ownership of 65.02% of AB Private Lending Fund's Class I Common Shares.

Insight Partners and affiliated entities have filed a Schedule 13G reporting beneficial ownership of 30,425,805 shares of Coursera, Inc. common stock.

Insight Venture Partners and affiliated entities have filed a Schedule 13G reporting a collective 6.3% beneficial ownership stake in EquipmentShare.com Inc.

ADAR1 Capital Management and Daniel Schneeberger have reported a 6% beneficial ownership stake in OnKure Therapeutics, Inc. as of March 31, 2026.

ADAR1 Capital Management and Daniel Schneeberger have filed a Schedule 13G reporting a 4.9% beneficial ownership stake in Quoin Pharmaceuticals, Ltd.

ADAR1 Capital Management and Daniel Schneeberger have reported a 9.9% beneficial ownership stake in Inhibikase Therapeutics, Inc.

Apollo Management Holdings and affiliated entities have filed a Schedule 13G reporting an 8.2% beneficial ownership stake in Community Health Systems, Inc.